Concepedia

Author

Davide Rossi

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”ORCID

Also Known As

Adrian Schmidt, Claudia Reali, D Rossi, D. Rossi, D.S. Rossi, Davide Massimiani, Davide Rossi, Davide Rossi°, H. Gomez, Immacolata Iannone

1.1K

Publications

28.4K

Citations

85

H-Index

148

Concepts

All Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Institute of Oncology ResearchIstituti di Ricovero e Cura a Carattere ScientificoCentro di Riferimento OncologicoUniversity of Turin
DR

About

Davide Rossi is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

43

84

7.5K

2

Health Sciences

11

12

611

3

Engineering

5

5

421

4

Business

1

1

12

5

Education

1

1

50

Davide Rossi

×

265

Publications

23.4K

Citations

79

H-Index

YearCitations

Analysis of the coding genome of diffuse large B-cell lymphoma

Laura Pasqualucci, Giulia Fabbri, Jing Ma,

Nature Genetics

2011

957

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

Laura Pasqualucci, David Dominguez-Sola, Annalisa Chiarenza,

Nature

2011

919

Analysis of the chronic lymphocytic leukemia coding genome: role of <i>NOTCH1</i> mutational activation

Giulia Fabbri, Silvia Rasi, Davide Rossi,

The Journal of Experimental Medicine

2011

602

Genetics of Follicular Lymphoma Transformation

Laura Pasqualucci, Hossein Khiabanian, Marco Fangazio,

Cell Reports

2014

571

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

David M. Kurtz, Florian Scherer, Michael C. Jin,

Journal of Clinical Oncology

2018

472

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

Davide Rossi, Silvia Rasi, Valeria Spina,

Blood

2012

454

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

Davide Rossi, Silvia Rasi, Giulia Fabbri,

Blood

2011

438

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Ramona Crescenzo, Francesco Abate, Elena Lasorsa,

Cancer Cell

2015

429

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli,

Journal of Clinical Oncology

2010

424

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Alessandra Larocca, Davide Rossi, Maide Cavalli,

Blood

2010

379

Page 1